Title : Acetylcholinesterase\/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia - Perry_2007_Leukemia_21_1472 |
Author(s) : Perry C , Pick M , Podoly E , Gilboa-Geffen A , Zimmerman G , Sklan EH , Ben-Shaul Y , Diamant S , Soreq H |
Ref : Leukemia , 21 :1472 , 2007 |
Abstract :
Hematological changes induced by various stress stimuli are accompanied by replacement of the primary acetylcholinesterase (AChE) 3' splice variant acetylcholinesterase-S (AChE-S) with the myelopoietic acetylcholinesterase-R (AChE-R) variant. To search for putative acetylcholinesterase-S interactions with hematopoietic pathways, we employed a yeast two-hybrid screen. The transcriptional co-repressor C-terminal binding protein (CtBP) was identified as a protein partner of the AChE-S C terminus. In erythroleukemic K562 cells, AChE-S displayed nuclear colocalization and physical interaction with CtBP. Furthermore, co-transfected AChE-S reduced the co-repressive effect of CtBP over the hematopoietic transcription factor, Ikaros. In transgenic mice, overexpressed human (h) AChE-S mRNA induced selective bone marrow upregulation of Ikaros while suppressing FOG, another transcriptional partner of CtBP. Transgenic bone marrow cells showed a correspondingly elevated potential for producing progenitor colonies, compared with controls, while peripheral blood showed increased erythrocyte counts as opposed to reduced platelets, granulocytes and T lymphocytes. AChE's 3' alternative splicing, and the corresponding changes in AChE-S/CtBP interactions, thus emerge as being actively involved in controlling hematopoiesis and the potential for modulating immune functions, supporting reports on malfunctioning immune reactions under impaired splice site selection. |
PubMedSearch : Perry_2007_Leukemia_21_1472 |
PubMedID: 17476278 |
Perry C, Pick M, Podoly E, Gilboa-Geffen A, Zimmerman G, Sklan EH, Ben-Shaul Y, Diamant S, Soreq H (2007)
Acetylcholinesterase\/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia
Leukemia
21 :1472
Perry C, Pick M, Podoly E, Gilboa-Geffen A, Zimmerman G, Sklan EH, Ben-Shaul Y, Diamant S, Soreq H (2007)
Leukemia
21 :1472